Ribavirin (Virazole) Inhalation

Aetna covers inhaled ribavirin (Virazole) as medically necessary for RSV in immunosuppressed and high‑risk children/adults (FDA‑approved for hospitalized infants/young children with severe RSV) and for certain viral hemorrhagic fevers (Crimean‑Congo, Ebola, Lassa, Marburg), Rift Valley fever, and Hantaan virus, with coverage subject to applicable selection criteria and ICD‑10 coding (e.g., A92.0–A92.9 where relevant). All other indications are considered experimental/investigational and not covered (examples: AML, COVID‑19, glioblastoma, foot‑and‑mouth disease).

"Clinical evidence supporting diagnosis (e."

Sign up to see full coverage criteria, indications, and limitations.